New migraine treatments a game changer for some patients

| | June 17, 2019
best and worst foods for migraines
Image: Frederic Cirou
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Chronic migraine disorder, which a neurologist diagnosed [Michelle] Tracy with shortly after her initial ER visit, is defined as having 15 or more days with a headache that lasts four hours or more, in a given month.

In May 2018, the first drug in this class, Aimovig, was approved by the U.S. Food and Drug Administration (FDA) for episodic and chronic migraine. Brought to market by the pharmaceutical company Amgen, Aimovig is a calcitonin gene-related peptide (CGRP) inhibitor. It prevents migraines by stopping a protein fragment called CGRP — which is involved in the formation of migraine attacks — from binding to CGRP receptors in the brain, effectively blocking the migraine from developing.

Related article:  Does listening to music make difficult tasks easier? That may depend on your personality

Within the calendar year, two more CGRP inhibitors, one from the pharmaceutical company Teva and the other from Eli Lilly, were also approved by the FDA. All come in the form of monthly or quarterly injections that can be self-administered at home into the upper arm, stomach, or thigh.

CGRP inhibitors were a long time coming, and while they don’t work for everyone, they’ve had a significant impact. “It’s changed my practice,” says Dr. Stewart Tepper, a professor of Neurology at the Geisel School of Medicine at Dartmouth.

Read full original post: Have We Reached a New Era of Migraine Treatment?

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
sperm swim

Video: Sperm are ‘spinners not swimmers’—because they are lopsided

Research by fertility scientists in the UK and Mexico challenges the accepted view of how sperm “swim”, suggesting that it ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
breastfeeding bed x facebook x

Infographic: We know breastfeeding helps children. Now we know it helps mothers too

When a woman becomes pregnant, her risk of type 2 diabetes increases for the rest of her life, perhaps because ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend